Switch study for people with insomnia using dolutegravir
8 October 2021. Related: Early access, Research studies.
Research studies
START study: call for participants to attend final visit – please help…
17 September 2021. Related: Research studies.
IAS 2021: Proving efficacy of next generation PrEP: counterfactual controls in lenacapavir and islatravir studies
1 August 2021. Related: Conference reports, HIV prevention and transmission, Research studies.
UK study for people with triple-class drug resistance
24 February 2021. Related: Resistance, Research studies.
US requires informed consent forms for clinical studies to be posted online
12 March 2019. Related: Research studies, Other news.
How to evaluate PrEP and vaccines: urgency for next generation compounds
13 November 2018. Related: Conference reports, HIV prevention and transmission, Cure research, Research studies.
ViiV announces phase 3 study switching to dolutegravir/3TC dual therapy from TAF-containing ART
9 February 2018. Related: Antiretrovirals, Research studies.
Updates from the PrEP IMPACT study – November 2017
28 November 2017. Related: HIV prevention and transmission, Research studies.
Exercise associated with significantly reduced risk of serious health problems and higher CD4 counts in large multicentre US study
1 October 2016. Related: Conference reports, Research studies.
Non-AIDS mortality in England and Wales in HIV positive vs general population
1 June 2016. Related: Conference reports, Ageing and life expectancy, Research studies.
Why START would make an excellent long-term cohort
1 December 2015. Related: Research studies.
Why dolutegravir might get us closer to ending AIDS: next step, further research
1 December 2015. Related: Research studies.